Non Small Cell Lung Cancer Ii Iii clinical trials

Explore recruiting non small cell lung cancer ii iii clinical trials.

Recruiting non small cell lung cancer ii iii studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Non Small Cell Lung Cancer Ii Iii trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II Multicenter, open label, non-randomized study of neoadjuvant and Adjuvant Treatment with IPH5201 and durvalumab in patients with resectable, early-Stage (II to III) Non-Small Cell Lung Cancer (MATISSE)

Hungary, Greece, Poland, France

Therapeutic exploratory (Phase II) EU CTIS Study details

Non Small Cell Lung Cancer Ii Iii trials by city

Non Small Cell Lung Cancer Ii Iii in Toronto Non Small Cell Lung Cancer Ii Iii in Vancouver Non Small Cell Lung Cancer Ii Iii in Montreal Non Small Cell Lung Cancer Ii Iii in Calgary Non Small Cell Lung Cancer Ii Iii in Edmonton Non Small Cell Lung Cancer Ii Iii in Ottawa Non Small Cell Lung Cancer Ii Iii in Winnipeg Non Small Cell Lung Cancer Ii Iii in Quebec City Non Small Cell Lung Cancer Ii Iii in Hamilton Non Small Cell Lung Cancer Ii Iii in Kitchener Non Small Cell Lung Cancer Ii Iii in London Non Small Cell Lung Cancer Ii Iii in Halifax Non Small Cell Lung Cancer Ii Iii in New York Non Small Cell Lung Cancer Ii Iii in Los Angeles Non Small Cell Lung Cancer Ii Iii in Chicago Non Small Cell Lung Cancer Ii Iii in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease